Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
Get 25% Off Sitewide on Cyber Monday Get 25% Off Sitewide on Cyber Monday

Top Health Official Cashes in on Merck Stock

Analysis by Dr. Joseph Mercola Fact Checked
  • March 06, 2020
    151509

Story at-a-glance

  • In January 2020, Dr. Julie Gerberding, former director of the U.S. Centers for Disease Control and Prevention, who after leaving the CDC became president of Merck’s vaccine division, sold half her Merck stock options for $9.11 million

WARNING!

This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.

 

Top

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.

I agree

Join the World’s #1 Natural Health Newsletter for FREE!
×

Please Sign in or Join to continue.